561 related articles for article (PubMed ID: 23280792)
21. A small-molecule inhibitor of SOD1-Derlin-1 interaction ameliorates pathology in an ALS mouse model.
Tsuburaya N; Homma K; Higuchi T; Balia A; Yamakoshi H; Shibata N; Nakamura S; Nakagawa H; Ikeda SI; Umezawa N; Kato N; Yokoshima S; Shibuya M; Shimonishi M; Kojima H; Okabe T; Nagano T; Naguro I; Imamura K; Inoue H; Fujisawa T; Ichijo H
Nat Commun; 2018 Jul; 9(1):2668. PubMed ID: 29991716
[TBL] [Abstract][Full Text] [Related]
22. Overexpressed wild-type superoxide dismutase 1 exhibits amyotrophic lateral sclerosis-related misfolded conformation in induced pluripotent stem cell-derived spinal motor neurons.
Komatsu K; Imamura K; Yamashita H; Julien JP; Takahashi R; Inoue H
Neuroreport; 2018 Jan; 29(1):25-29. PubMed ID: 29140847
[TBL] [Abstract][Full Text] [Related]
23. Adverse effects of a SOD1-peptide immunotherapy on SOD1 G93A mouse slow model of amyotrophic lateral sclerosis.
Sábado J; Casanovas A; Rodrigo H; Arqué G; Esquerda JE
Neuroscience; 2015 Dec; 310():38-50. PubMed ID: 26384962
[TBL] [Abstract][Full Text] [Related]
24. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
[TBL] [Abstract][Full Text] [Related]
25. Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.
Gros-Louis F; Soucy G; Larivière R; Julien JP
J Neurochem; 2010 Jun; 113(5):1188-99. PubMed ID: 20345765
[TBL] [Abstract][Full Text] [Related]
26. An oligomer-specific antibody improved motor function and attenuated neuropathology in the SOD1-G93A transgenic mouse model of ALS.
Dong QX; Zhu J; Liu SY; Yu XL; Liu RT
Int Immunopharmacol; 2018 Dec; 65():413-421. PubMed ID: 30388515
[TBL] [Abstract][Full Text] [Related]
27. [Implications of successful immunotherapy in ALS model mice].
Urushitani M
Brain Nerve; 2008 Jun; 60(6):643-51. PubMed ID: 18567360
[TBL] [Abstract][Full Text] [Related]
28. Identification of a misfolded region in superoxide dismutase 1 that is exposed in amyotrophic lateral sclerosis.
Rotunno MS; Auclair JR; Maniatis S; Shaffer SA; Agar J; Bosco DA
J Biol Chem; 2014 Oct; 289(41):28527-38. PubMed ID: 25164820
[TBL] [Abstract][Full Text] [Related]
29. A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS.
Nagano S; Takahashi Y; Yamamoto K; Masutani H; Fujiwara N; Urushitani M; Araki T
Hum Mol Genet; 2015 Jun; 24(12):3427-39. PubMed ID: 25762155
[TBL] [Abstract][Full Text] [Related]
30. SOD1 as a molecular switch for initiating the homeostatic ER stress response under zinc deficiency.
Homma K; Fujisawa T; Tsuburaya N; Yamaguchi N; Kadowaki H; Takeda K; Nishitoh H; Matsuzawa A; Naguro I; Ichijo H
Mol Cell; 2013 Oct; 52(1):75-86. PubMed ID: 24076220
[TBL] [Abstract][Full Text] [Related]
31. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
32. Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress.
Cookson MR; Menzies FM; Manning P; Eggett CJ; Figlewicz DA; McNeil CJ; Shaw PJ
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):75-85. PubMed ID: 12215229
[TBL] [Abstract][Full Text] [Related]
33. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
34. Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis.
Liu HN; Tjostheim S; Dasilva K; Taylor D; Zhao B; Rakhit R; Brown M; Chakrabartty A; McLaurin J; Robertson J
J Neurosci; 2012 Jun; 32(26):8791-9. PubMed ID: 22745481
[TBL] [Abstract][Full Text] [Related]
35. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis.
Parone PA; Da Cruz S; Han JS; McAlonis-Downes M; Vetto AP; Lee SK; Tseng E; Cleveland DW
J Neurosci; 2013 Mar; 33(11):4657-71. PubMed ID: 23486940
[TBL] [Abstract][Full Text] [Related]
36. Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS.
Ezzi SA; Larivière R; Urushitani M; Julien JP
J Neurochem; 2010 Dec; 115(5):1102-11. PubMed ID: 20807312
[TBL] [Abstract][Full Text] [Related]
37. Mechanism for transforming cytosolic SOD1 into integral membrane proteins of organelles by ALS-causing mutations.
Lim L; Lee X; Song J
Biochim Biophys Acta; 2015 Jan; 1848(1 Pt A):1-7. PubMed ID: 25306968
[TBL] [Abstract][Full Text] [Related]
38. An RNAi strategy for treatment of amyotrophic lateral sclerosis caused by mutant Cu,Zn superoxide dismutase.
Xia XG; Zhou H; Zhou S; Yu Y; Wu R; Xu Z
J Neurochem; 2005 Jan; 92(2):362-7. PubMed ID: 15663483
[TBL] [Abstract][Full Text] [Related]
39. Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases.
Ayers JI; Xu G; Pletnikova O; Troncoso JC; Hart PJ; Borchelt DR
Acta Neuropathol Commun; 2014 May; 2():55. PubMed ID: 24887207
[TBL] [Abstract][Full Text] [Related]
40. Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form.
Kerman A; Liu HN; Croul S; Bilbao J; Rogaeva E; Zinman L; Robertson J; Chakrabartty A
Acta Neuropathol; 2010 Mar; 119(3):335-44. PubMed ID: 20111867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
